This month’s Nature Medicine features a question and answer interview with Marc Hodosh, senior director of the Archon X prize, who explains why genomics was chosen for an X prize and predicts what lies ahead for the field (Nat. Med. 14, 8 ; 2008). These days, if you want to have your entire genome sequenced, you need to spend about a million dollars and wait for months. The Archon X prize for genomics—an international competition for speedy gene mapping—might change this by giving companies a huge incentive to develop better DNA sequencing technologies. The $10 million prize, first announced in late 2006, was donated by Stewart Blusson, a philanthropist and mining multimillionaire. Announcement of a winner, thinks Hodosh, is probably two to four years away. Read the full article, by Genevive Bjorn, at the Nature Medicine website.